MRI Characterizes the Progressive Course of AD and Predicts Conversion to Alzheimer’s Dementia 24 Months Before Probable Diagnosis

MRI Characterizes the Progressive Course of AD and Predicts Conversion to Alzheimer’s Dementia 24 Months Before Probable Diagnosis

There is no disease-modifying treatment currently available for AD, one of the more impacting neurodegenerative diseases affecting more than 47.5 million people worldwide. The definition of new approaches for the design of proper clinical trials is highly demanded in order to achieve non-confounding...

Full description

Bibliographic Details
Main Authors: Christian Salvatore, Antonio Cerasa, Isabella Castiglioni
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Aging Neuroscience
Subjects:
artificial intelligence
Alzheimer’s disease
clinical trials
magnetic resonance imaging
neuropsychological tests
biomarkers
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2018.00135/full

Similar Items

Similar Items